Following a formal request from Mercedes, the Nuerburgring Langstrecken-Serie moved its second race of the season back by one week to slide into an F1 offweek, in the hopes of courting four-time ...
ZURICH - NLS Pharmaceutics Ltd. (NASDAQ:NLSP) announced Thursday the expansion of its DOXA platform with a new series of small molecules targeting arousal stability, cognition, and neuroprotection.
NewcelX Ltd. ("NewcelX" or the "Company") completed the previously announced merger transaction, pursuant to that certain Agreement of Merger and Plan of Reorganization, as amended from time to time, ...
NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025
ZURICH, Oct. 23, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) (Nasdaq: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company ...
SEOUL, KOREA — Suprema has used the spotlight at GSX 2025 to demonstrate its BioStar Air, a cloud-based access control platform designed to natively support biometric authentication. Suprema said it ...
Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from NLS Pharmaceutics ( (NLSP) ...
BIOSTAR, a leading manufacturer of edge computing solutions, motherboards, graphics cards, and storage devices, proudly concludes a highly successful COMPUTEX TAIPEI 2025 showcase. This year's ...
SEOUL, KOREA May 7, 2025 – Suprema, a global leader in AI-powered access control and security solutions, officially announced the launch of BioStar Air, the first and only cloud-based access control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results